Kinnevik AB (publ)
STOCKHOLM, V7
$66m in 1 US stocks at the end of 30 September 2025. The top 10 are 100.0% of the money. It changed about 0.0% of the portfolio this quarter.
Value
$66m
Stocks
1
Top 10 share
100.0%
Turnover
0.0%
What changed this quarter
New
Bought for the first time this quarter.
None this quarter.
Added
Bought more of a stock they already held.
None this quarter.
Cut
Sold some of their stake.
None this quarter.
Sold out
Sold their entire stake.
None this quarter.
Holdings
| Company | Share of fund | Value | Shares | Change |
|---|---|---|---|---|
| Recursion PharmaceuticalsRXRX | 100.0% | $66m | 13,434,171 | Held |
Over time and by industry
Value over time
Sep '25
Value is down 3.6% since 30 June 2025.
Where the money is
Health care100.0%
From the fund's 13F filings. They list US stocks and options only, 45 days after each quarter, and leave out cash, bonds, shorts and foreign shares.